H.J.P Fokkenrood

Innovative strategies for
intermittent claudication

towards a stepped care approach and new outcome measures

MENU

CONCLUSION


 The present review demonstrates that SET can safely be prescribed in IC patients because cardiovascular complication rates associated with this type of therapy are extremely low. However, caution should be taken when applying these results in patients with major comorbidity.